What is it about?
a very good response related to antiviral drugs against HCV mixed cryoglobulinemia
Featured Image
Read the Original
This page is a summary of: Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience, Infection and Drug Resistance, June 2018, Dove Medical Press,
DOI: 10.2147/idr.s167093.
You can read the full text:
Contributors
The following have contributed to this page